Introduction
Alzheimer's disease stands as the most prevalent cause of dementia, a condition characterized by the progressive decline of cognitive functions such as memory, thinking, and behavior. This debilitating illness not only affects the individuals diagnosed but also places a significant burden on their families and caregivers. The likelihood of developing Alzheimer's disease increases substantially with age, making it a growing public health concern in an aging global population. This report aims to provide a comprehensive explanation of the biological mechanisms underlying Alzheimer's, explore the key risk factors associated with its development, detail the spectrum of symptoms that manifest throughout the disease's progression, underscore the critical role of early detection, and highlight the ongoing research efforts dedicated to combating this complex condition. It is crucial to recognize that Alzheimer's is not a natural part of aging; rather, it is a distinct pathological process with identifiable early signs that warrant medical attention. Differentiating between typical age-related forgetfulness and the initial indicators of Alzheimer's is the first step towards timely intervention and management.
The Underlying Biology: Amyloid Plaques and Tau Tangles
At the core of Alzheimer's disease are two abnormal protein structures that accumulate in the brain: amyloid-beta plaques and neurofibrillary tangles. These protein abnormalities are considered hallmarks of the disease and are believed to disrupt the normal functioning of the brain, ultimately leading to the cognitive decline observed in affected individuals. While the presence of both amyloid plaques and tau tangles is characteristic of Alzheimer's, the precise causal relationship between them and the exact mechanisms through which they contribute to neurodegeneration remain areas of active investigation.
Amyloid Plaques: Clumps Outside the Neurons
Amyloid plaques are extracellular deposits primarily composed of the beta-amyloid protein. This protein fragment originates from the breakdown of a larger protein called the amyloid precursor protein (APP). Normally, beta-amyloid exists as soluble monomers; however, in Alzheimer's disease, these monomers exhibit a tendency to become "sticky" and aggregate, forming insoluble clumps or plaques in the spaces between neurons. The beta-amyloid 42 form is considered particularly toxic to brain cells due to its greater propensity to form these harmful aggregates. The accumulation of these plaques can physically obstruct communication between neurons, hindering the intricate signaling processes essential for brain functions like memory. Furthermore, the presence of amyloid plaques can trigger an immune response in the brain, leading to inflammation that may inadvertently damage surrounding neurons. In some instances, amyloid plaques can also deposit around blood vessels in the brain, a condition known as amyloid angiopathy, which weakens the vessel walls and increases the risk of hemorrhage. The abnormal production of beta-amyloid is often linked to the action of specific enzymes, including beta-secretase and gamma-secretase. In healthy individuals, the brain possesses mechanisms to clear amyloid-beta through systemic circulation and the action of immune cells called microglia. However, in Alzheimer's disease, this clearance mechanism may become impaired, contributing to the buildup of amyloid and the formation of plaques. Notably, microglia, the brain's primary immune cells, exhibit a complex role in the context of amyloid plaques. Initially, they attempt to clear these deposits, but as the disease progresses, their function can become less effective or even counterproductive, potentially contributing to further damage
Tau Tangles: Knots Inside the Neurons
Neurofibrillary tangles, the second hallmark of Alzheimer's, are found inside neurons and are composed of an abnormally modified protein called tau. In healthy neurons, tau protein plays a crucial role in stabilizing microtubules, which are structural components of the neuron's cytoskeleton responsible for transporting nutrients and other essential molecules throughout the cell. In Alzheimer's disease, however, an abnormal process called phosphorylation causes tau to detach from the microtubules and instead clump together, forming thread-like structures that eventually develop into neurofibrillary tangles within the neuron. These tangles disrupt the neuron's internal transport system, impairing communication between cells and ultimately leading to the death of the affected neurons through a process called apoptosis. It is believed that the accumulation of amyloid plaques outside the neuron may initiate a cascade of events inside the neuron that results in the abnormal changes in tau protein. Interestingly, the development of tau pathology within the brain might begin as early as 15 years before the emergence of any noticeable clinical symptoms. This suggests a long preclinical phase during which these microscopic changes are silently occurring. The relationship between amyloid-beta and tau appears to be one where the accumulation of amyloid may precede and contribute to the development of tau tangles, highlighting a potential sequential or synergistic interaction between these two protein abnormalities.
Neuron Damage and Brain Atrophy
The combined effect of amyloid plaques and neurofibrillary tangles leads to significant damage to neurons, resulting in synaptic dysfunction and the eventual loss of these critical brain cells. This neuronal damage manifests as a thinning of the brain's outer layer, known as the cortex (cortical atrophy), and a noticeable decrease in overall brain volume, particularly in regions crucial for memory, such as the hippocampus. Furthermore, studies indicate a reduction in the brain's ability to utilize glucose for energy in individuals with Alzheimer's, further impacting neuronal function due to the high energy demands of these cells. The progression of Alzheimer's symptoms closely correlates with the spread of both amyloid and tau pathology to different regions of the brain, each responsible for specific cognitive functions. As the disease advances, the damage extends beyond the initial memory areas to encompass regions involved in language, reasoning, and even basic bodily functions, explaining the increasingly wide range and severity of symptoms observed over time.
Key Risk Factors for Alzheimer's
While the precise mechanisms that trigger Alzheimer's disease remain elusive, several factors have been consistently identified as increasing an individual's risk of developing the condition.
Age
Advanced age stands out as the most significant known risk factor for Alzheimer's disease. The likelihood of being diagnosed with Alzheimer's roughly doubles every five years after the age of 65. While the majority of cases occur in individuals over this age (referred to as late-onset Alzheimer's), it is important to note that Alzheimer's can also affect people younger than 65, sometimes even in their 30s or 40s; this is known as early-onset Alzheimer's. The aging process naturally brings about various changes in the brain, such as the shrinkage of certain brain regions, increased inflammation, damage to blood vessels, the production of unstable molecules called free radicals, and a decline in energy production within cells. These age-related changes are believed to potentially contribute to the vulnerability of the brain to Alzheimer's-related damage.
Genetics
Genetic factors also play a significant role in influencing an individual's risk of developing Alzheimer's. Having a family history of the disease, particularly if a first-degree relative such as a parent or sibling has been diagnosed, increases the likelihood of developing Alzheimer's. One well-studied gene associated with Alzheimer's risk is the apolipoprotein E (APOE) gene. The APOE gene comes in several forms, or alleles, with the APOE ε4 allele being associated with an increased risk of developing Alzheimer's and potentially an earlier age of onset. It is important to remember, however, that not everyone who carries the APOE ε4 allele will ultimately develop the disease. In a small percentage of cases, rare genetic mutations in three specific genes – the amyloid precursor protein (APP) gene, the presenilin 1 (PSEN1) gene, and the presenilin 2 (PSEN2) gene – are known to directly cause familial Alzheimer's disease. Inheriting one of these altered genes carries a very high probability of developing Alzheimer's, often at a younger age, typically before 65. Furthermore, individuals with Down syndrome have a significantly elevated risk of developing Alzheimer's disease. This increased risk is likely due to the fact that they possess an extra copy of chromosome 21, which contains the gene for APP, leading to an increased production of beta-amyloid and a higher likelihood of amyloid plaque buildup in the brain, often resulting in earlier onset of Alzheimer's symptoms. While genetics certainly contributes to Alzheimer's risk, especially in early-onset cases, the vast majority of Alzheimer's diagnoses are believed to arise from a complex interplay of genetic predispositions combined with lifestyle and environmental factors.
Lifestyle and Health
A growing body of research highlights a strong connection between brain health and cardiovascular health, suggesting that factors that negatively impact the heart and blood vessels may also increase the risk of Alzheimer's disease. Several cardiovascular risk factors have been linked to an elevated risk of Alzheimer's, including high blood pressure, high cholesterol levels, type 2 diabetes, obesity, and smoking. Adopting a heart-healthy lifestyle, which includes regular exercise, a balanced diet rich in fruits, vegetables, and healthy fats, avoiding smoking, and moderating alcohol consumption, may contribute to reducing the risk of Alzheimer's by promoting overall brain health. Additionally, other potential risk factors are currently under investigation, such as a history of head injuries, exposure to air pollution, hearing loss, untreated depression, social isolation and loneliness, and a sedentary lifestyle. These findings suggest that modifiable lifestyle choices offer potential avenues for individuals to take proactive steps towards protecting their brain health and potentially lowering their risk of developing Alzheimer's disease.
Early Signs and Symptoms: Recognizing the Initial Changes
The initial signs and symptoms of Alzheimer's disease can be subtle and may vary considerably from one individual to another. However, memory problems, particularly difficulty remembering recent events and conversations, are frequently among the first noticeable indicators of the disease. It is important to be aware of the following common early signs and symptoms that may warrant further medical evaluation:
- Memory loss that disrupts daily life: This goes beyond occasional forgetfulness and includes forgetting important information, recent conversations, or asking the same questions repeatedly.
- Challenges in planning or problem-solving: Individuals may experience difficulty with tasks that require planning, such as managing finances or following a recipe.
- Difficulty completing familiar tasks: Routine activities at home, work, or during leisure time may become increasingly challenging to perform.
- Confusion with time or place: This can involve losing track of dates, the time of day, or feeling disoriented in familiar surroundings.
- Trouble understanding visual images and spatial relations: Problems with depth perception, judging distances, or interpreting visual cues may arise.
- New problems with words in speaking or writing: Finding the right words to express thoughts or follow conversations can become difficult.
- Misplacing things and not being able to retrace steps: Objects may be put in unusual places, and the person may be unable to remember where they were last seen.
- Decreased or poor judgment: Making poor decisions in everyday situations, such as with finances, may occur.
- Withdrawal from work or social activities: A loss of interest in hobbies, social engagements, or work-related activities may be observed.
- Changes in mood and personality: Increased irritability, anxiety, agitation, depression, or suspicion may manifest.
Often, family members and close friends may notice these subtle changes before the individual experiencing them becomes fully aware of the extent of the problem. It is also worth noting the condition of mild cognitive impairment (MCI), where individuals exhibit more memory problems than typically expected for their age but are still able to function independently in their daily lives. While MCI can sometimes be an early stage of Alzheimer's, it does not always progress to the full-blown disease. It is crucial to recognize that these early symptoms can sometimes be mistakenly attributed to normal aging or other conditions such as stress, depression, or infections. Therefore, seeking a comprehensive medical evaluation is essential for accurate diagnosis and appropriate management. Memory problems are not always indicative of Alzheimer's and can have various treatable underlying causes, further emphasizing the importance of professional assessment.
The Progression of Symptoms: Cognitive and Behavioral Changes Over Time
As Alzheimer's disease progresses, the initial memory problems tend to worsen, and a wider range of cognitive and behavioral changes emerge. The middle stage of Alzheimer's, often referred to as moderate dementia, is characterized by more pronounced difficulties :
- Increasing confusion and disorientation: Individuals may become more frequently confused about their location, the time of day, or even the season. They might get lost in familiar places and struggle to find their way home.
- Difficulty remembering names and recognizing people: Remembering the names of acquaintances and even close friends and family members becomes increasingly challenging, and individuals may have trouble recognizing familiar faces.
- Problems with speech and language (aphasia): Finding the right words, expressing thoughts clearly, and understanding conversations become significantly impaired.
- Obsessive, repetitive, or impulsive behavior: Repetitive actions, asking the same questions repeatedly, or engaging in impulsive behaviors may occur.
- Delusions (believing untrue things) or paranoia: Individuals may develop false beliefs or become increasingly suspicious of others.
- Disturbed sleep patterns: Changes in sleep-wake cycles, such as increased daytime sleeping and nighttime restlessness, are common.
- Significant mood swings, depression, anxiety, frustration, or agitation: Emotional regulation becomes more difficult, leading to frequent and sometimes unpredictable mood changes.
- Difficulty performing spatial tasks: Tasks requiring spatial awareness, such as judging distances or navigating, become more challenging.
- Hallucinations (seeing or hearing things that aren't there): Some individuals may experience visual or auditory hallucinations.
- Increasing need for support with daily living activities: Tasks such as eating, washing, dressing, and using the toilet may require assistance from caregivers.
In the later stage of Alzheimer's, known as severe dementia, the symptoms become increasingly severe and can be deeply distressing for both the individual and their caregivers:
- Difficulty eating and swallowing (dysphagia): This can lead to weight loss and an increased risk of aspiration pneumonia, a serious lung infection that can occur when food or liquid enters the lungs.
- Difficulty changing position or moving around without assistance: Individuals may become increasingly immobile, eventually becoming bedridden and requiring complete assistance with movement.
- Unintentional passing of urine (urinary incontinence) or stools (bowel incontinence): Loss of bladder and bowel control is common in the late stages.
- Gradual loss of speech and communication abilities: Communication becomes severely limited, and individuals may eventually lose the ability to speak or understand language.
- Significant problems with both short-term and long-term memory: Memory loss becomes profound, and individuals may lose awareness of recent experiences and their surroundings.
- Increased risk of infections: Due to immobility and difficulties with eating and swallowing, individuals in the late stages are highly susceptible to infections, which are often the ultimate cause of death.
The progression of Alzheimer's is characterized by a gradual and continuous decline in cognitive and functional abilities, ultimately leading to a state of complete dependence on others for all aspects of care. It is important to remember that the rate at which the disease progresses can vary considerably among individuals. Interestingly, even in the later stages, some abilities, often referred to as "preserved skills," may remain relatively intact. These can include the ability to read, listen to music, or recall certain memories.
| Symptom Category | Early Stage Symptoms | Middle Stage Symptoms | Late Stage Symptoms |
|---|---|---|---|
| Memory | Forgetting recent events, trouble recalling newly learned information, repeating questions | Increasing memory loss and confusion, forgetting personal history details | Severe memory loss, unaware of recent experiences and surroundings |
| Language | Trouble finding the right word, difficulty expressing thoughts | Problems with reading, writing, and speaking (aphasia), difficulty understanding language | Minimal to no speech, inability to communicate |
| Behavior | Mild mood changes, anxiety, irritability | Agitation, wandering, restlessness, sleep disturbances, personality changes, delusions, paranoia, hallucinations | Potential for increased agitation or passivity, significant behavioral changes |
| Daily Activities | Difficulty with complex tasks, managing finances | Need help with dressing, bathing, and other self-care activities, difficulty with familiar routines | Complete dependence on others for all daily care activities, including eating, dressing, and personal hygiene |
Table: Comparison of Early, Middle, and Late-Stage Alzheimer's Symptoms
The Importance of Early Detection and Diagnosis
While currently there is no cure for Alzheimer's disease, early detection and accurate diagnosis offer a multitude of significant benefits for individuals and their families. Receiving a timely diagnosis provides access to crucial information, resources, and support networks for both the person diagnosed and their loved ones. Early diagnosis also opens the door to participating in clinical trials for potential new treatments that may slow the progression of the disease or alleviate symptoms. Furthermore, individuals diagnosed early can benefit from currently available treatments, including medications and non-pharmacological therapies, which can help manage symptoms such as memory loss and confusion, and potentially slow cognitive decline, especially with the advent of newer anti-amyloid drugs. Making informed lifestyle changes, such as adopting a healthier diet and engaging in regular physical and mental exercise, may also help individuals prioritize their health and potentially preserve cognitive function for longer. Emotionally, receiving an early diagnosis can lessen anxieties associated with unexplained symptoms, allowing individuals and their families to maximize their time together and access vital support programs. It also provides more time to plan for the future, including making important legal, financial, and end-of-life decisions according to the individual's wishes. Understanding the diagnosis empowers individuals to better comprehend what is happening to them and to actively participate in managing their condition. Importantly, early evaluation can help identify and treat other reversible medical conditions that may mimic the symptoms of dementia, such as depression, infections, or thyroid problems. From an economic perspective, early diagnosis has the potential to lead to long-term cost savings in healthcare and long-term care. Advancements in diagnostic tools are continuously being made, with the development of highly accurate blood tests capable of detecting biomarkers like tau protein showing great promise for revolutionizing early diagnosis. Currently, diagnosing Alzheimer's involves a comprehensive assessment that includes evaluating biomarkers through blood tests or cerebrospinal fluid analysis, as well as utilizing various cognitive tests to assess memory, attention, language, and problem-solving abilities. Doctors may employ standardized cognitive screening tools like the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA). Neuroimaging techniques, such as positron emission tomography (PET) scans and single-photon emission computed tomography (SPECT) imaging, can also play a crucial role in detecting amyloid plaque deposition and identifying patterns of brain activity and function that are characteristic of Alzheimer's disease.
Ongoing Research: Advancing Our Understanding and the Search for Solutions
Research into Alzheimer's disease is a dynamic and rapidly evolving field, with numerous ongoing initiatives focused on unraveling the complexities of the disease, developing effective treatments, and ultimately discovering a cure. A significant area of focus involves understanding the intricate interplay between amyloid-beta and tau proteins, as well as the role of the brain's immune cells, particularly microglia, in the development and progression of the disease. The development and clinical testing of drugs that target beta-amyloid, such as lecanemab and donanemab, represent a major step forward, demonstrating the potential to slow cognitive decline in individuals with early-stage Alzheimer's. Large-scale collaborative research initiatives, such as the Alzheimer's Disease Neuroimaging Initiative (ADNI) and its global counterpart, the World Wide Alzheimer's Disease Neuroimaging Initiative (WW-ADNI), are crucial for identifying reliable biomarkers that can facilitate earlier diagnosis and enable the monitoring of disease progression through the sharing of research data and expertise. Organizations like the Alzheimer's Association play a vital role in funding research projects and fostering collaboration among scientists worldwide. Current research efforts encompass a wide range of areas: developing innovative diagnostic tools for earlier and more accurate detection; investigating the potential of modulating the brain's immune system as a therapeutic strategy; exploring the specific roles of various proteins and enzymes involved in the disease process; conducting clinical trials to evaluate the efficacy of novel drug therapies and lifestyle interventions; and improving the overall care and support provided to individuals living with dementia. Participation in clinical trials is essential for advancing scientific knowledge and offers individuals the opportunity to potentially benefit from cutting-edge treatments. The rapid advancements in our understanding of Alzheimer's, coupled with the development of new diagnostic methods and potential disease-modifying therapies, offer a sense of hope for the future in the ongoing fight against this devastating illness.
Conclusion
Alzheimer's disease remains a complex and devastating condition with a profound impact on individuals, their families, and society as a whole. While the exact causes are still being investigated, significant progress has been made in understanding the underlying biological mechanisms, identifying key risk factors, and recognizing the spectrum of symptoms that characterize the disease. The presence of amyloid plaques and neurofibrillary tangles in the brain are hallmarks of Alzheimer's, leading to neuronal damage and progressive cognitive decline. Age, genetics, and lifestyle factors, particularly cardiovascular health, play significant roles in influencing an individual's risk. Recognizing the early signs and symptoms is crucial for prompt medical evaluation and diagnosis. Although there is currently no cure, early detection offers numerous benefits, including access to support, potential treatments, and the opportunity to plan for the future. Ongoing research efforts are continuously advancing our understanding of Alzheimer's, leading to the development of new diagnostic tools and promising therapeutic interventions. Continued dedication to research and increased awareness of this complex condition offer hope for improving the lives of those affected by Alzheimer's disease and ultimately finding effective ways to combat it.
Works cited
- Alzheimer's disease - Symptoms and causes - Mayo Clinic, accessed March 24, 2025, https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447
- Stages of Alzheimer's Disease | Johns Hopkins Medicine, accessed March 24, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/alzheimers-disease/stages-of-alzheimer-disease
- Mechanisms of Alzheimer's Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors - PubMed Central, accessed March 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5290713/
- Alzheimer's disease - Causes - NHS, accessed March 24, 2025, https://www.nhs.uk/conditions/alzheimers-disease/causes/
- What Causes Alzheimer's Disease? - National Institute on Aging, accessed March 24, 2025, https://www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/what-causes-alzheimers-disease
- What are the Causes and Risk Factors of Alzheimer's and Other Dementias?, accessed March 24, 2025, https://www.alz.org/alzheimers-dementia/what-is-alzheimers/causes-and-risk-factors
- Signs and Symptoms of Alzheimer's | Alzheimer's Disease and Dementia - CDC, accessed March 24, 2025, https://www.cdc.gov/alzheimers-dementia/signs-symptoms/alzheimers.html
- What Are the Signs of Alzheimer's Disease? | National Institute on Aging, accessed March 24, 2025, https://www.nia.nih.gov/health/alzheimers-symptoms-and-diagnosis/what-are-signs-alzheimers-disease
- Alzheimer's disease - plaques, tangles, causes, symptoms & pathology - YouTube, accessed March 24, 2025, https://www.youtube.com/watch?v=v5gdH_Hydes
- Key mechanisms in asymptomatic Alzheimer's disease brains may protect against cognitive decline - Indiana University School of Medicine, accessed March 24, 2025, https://medicine.iu.edu/news/2024/09/key-mechanisms-asymptomatic-alzheimers-disease-protect-against-cognitive-decline
- Mechanism of Alzheimer's Disease - YouTube, accessed March 24, 2025, https://m.youtube.com/watch?v=bQsgiBh0QCY&t=0s
- What Happens to the Brain in Alzheimer's Disease? | National Institute on Aging, accessed March 24, 2025, https://www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/what-happens-brain-alzheimers-disease
- What are Alzheimer's Plaques and Tangles? - BrightFocus, accessed March 24, 2025, https://www.brightfocus.org/resource/what-are-alzheimers-plaques-and-tangles/
- Alzheimer's Disease Fact Sheet | National Institute on Aging, accessed March 24, 2025, https://www.nia.nih.gov/health/alzheimers-and-dementia/alzheimers-disease-fact-sheet
- Alzheimer's missing link ID'd, answering what tips brain's decline - WashU Medicine, accessed March 24, 2025, https://medicine.washu.edu/news/alzheimers-missing-link-id-answering-what-tips-brains-decline/
- Amyloid and tau: the proteins involved in dementia, accessed March 24, 2025, https://www.dementiasplatform.uk/news-and-media/blog/amyloid-and-tau-the-proteins-involved-in-dementia
- Early-Onset Alzheimer's Disease | Johns Hopkins Medicine, accessed March 24, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/alzheimers-disease/earlyonset-alzheimer-disease
- Our Research Projects | Alzheimer's Foundation of America, accessed March 24, 2025, https://alzfdn.org/about-us/research-projects/
- Risk factors and risk reduction | Alzheimer's Disease International (ADI), accessed March 24, 2025, https://www.alzint.org/about/risk-factors-risk-reduction/
- Alzheimer's disease - Symptoms - NHS, accessed March 24, 2025, https://www.nhs.uk/conditions/alzheimers-disease/symptoms/
- Benefits of Early Diagnosis - Wisconsin Alzheimer's Institute, accessed March 24, 2025, https://wai.wisc.edu/benefits-of-early-diagnosis/
- Why spotting the early signs of dementia is so important - Alzheimer's Society, accessed March 24, 2025, https://www.alzheimers.org.uk/blog/why-spotting-early-signs-dementia-important
- Importance of a timely diagnosis | Alzheimer's Disease International (ADI), accessed March 24, 2025, https://www.alzint.org/about/symptoms-of-dementia/importance-of-early-diagnosis/
- Why Get Checked | Alzheimer's Association, accessed March 24, 2025, https://www.alz.org/alzheimers-dementia/diagnosis/why-get-checked
- The 7 Stages of Alzheimer's Disease - Penn Medicine, accessed March 24, 2025, https://www.pennmedicine.org/updates/blogs/neuroscience-blog/2019/november/stages-of-alzheimers
- Alzheimer's stages: How the disease progresses - Mayo Clinic, accessed March 24, 2025, https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers-stages/art-20048448
- Navigating Early Alzheimer's Diagnosis: A Comprehensive Review of Diagnostic Innovations - PMC, accessed March 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10561010/
- Dementia Research and Progress | Alzheimer's Association, accessed March 24, 2025, https://www.alz.org/alzheimers-dementia/research-and-progress
- Our Commitment to Global Research - Alzheimer's Association, accessed March 24, 2025, https://www.alz.org/alzheimers-dementia/research-and-progress/our_commitment
- Current research projects | Alzheimer's Society, accessed March 24, 2025, https://www.alzheimers.org.uk/research/our-research/research-projects
- ADNI | Alzheimer's Disease Neuroimaging Initiative, accessed March 24, 2025, https://adni.loni.usc.edu/
